Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877
NCT00471367
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
44
Enrollment
INDUSTRY
Sponsor class
Stopped
Part B of the study was terminated early due to a lack of enrollment.
Conditions
Lymphoma
NHL
Non-Hodgkin Lymphoma
Interventions
DRUG:
AZD4877
Sponsor
AstraZeneca